ANI PHARMACEUTICALS INC's ticker is and the CUSIP is 00182CAA1. A total of 20 filers reported holding ANI PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $39,173,000 | -22.5% | 36,000,000 | -12.7% | 2.40% | -6.0% |
| Q2 2019 | $50,569,000 | +10.2% | 41,256,000 | 0.0% | 2.55% | -6.2% |
| Q1 2019 | $45,886,000 | +18.1% | 41,256,000 | +7.5% | 2.72% | +6.0% |
| Q4 2018 | $38,855,000 | -14.7% | 38,381,000 | -9.7% | 2.56% | -6.1% |
| Q3 2018 | $45,559,000 | +34.6% | 42,501,000 | +42.9% | 2.73% | +34.8% |
| Q2 2018 | $33,847,000 | – | 29,751,000 | – | 2.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 46,542 | $43,298,000 | 2.53% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,000,000 | $7,370,000 | 0.75% |
| DINSMORE CAPITAL MANAGEMENT CO/NJ | 1,500,000 | $1,388,000 | 0.60% |
| Perceptive Advisors | 15,000,000 | $13,846,000 | 0.55% |
| WOLVERINE ASSET MANAGEMENT LLC | 15,211,000 | $14,296,000 | 0.34% |
| LINDEN ADVISORS LP | 3,500,000 | $3,258,000 | 0.22% |
| Visium Asset Management, LP | 6,500,000 | $6,067,000 | 0.08% |
| ZAZOVE ASSOCIATES LLC | 1,750,000 | $1,625,000 | 0.08% |
| Investors Capital Advisory Services | 326,000 | $300,000 | 0.06% |
| LAZARD ASSET MANAGEMENT LLC | 15,969,000 | $14,771,000 | 0.04% |